Better Health, Brighter Future
Our Products in Australia
We are committed to bringing better health and a brighter future to patients by translating science into highly innovative medicines. Our R&D efforts are focused on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
The following products are available from Takeda Pharmaceuticals Australia. For products available from Takeda Pharmaceuticals New Zealand please click here
Adcetris® (brentuximab vedotin)
Advate® (octocog alfa)
Adynovate® (rurioctocog alfa pegol)
Agrylin® (anagrelide hydrochloride)
Alunbrig® (brigatinib)
Ceprotin® (protein C, human)
Cuvitru® (normal immunoglobulin (human))
Entyvio® (vedolizumab)
Feiba NF® (Factor VIII inhibitor bypassing fraction)
Firazyr® (icatibant acetate)
Fosrenol® (lanthanum carbonate hydrate)
Hyqvia® (normal immunoglobulin infusion 10% (human) with vorhyaluronidase alfa)
Iclusig® (ponatinib hydrochloride)
Intuniv® (guanfacine hydrochloride)
Kiovig® (normal immunoglobulin (human) 10%)
Livtencity® (maribavir)
Mezavant® (mesalazine)
Mesalazine 1.2 Takeda®
Nesina® (alogliptin benzoate) and Nesina Met® (alogliptin benzoate / metformin hydrochloride)
- Product Information (Nesina®)
- Product Information (Nesina Met®)
- Consumer Medicine Information (Nesina®)
- Consumer Medicine Information (Nesina Met®)
Obizur® (recombinant porcine coagulation factor VIII, B-domain deleted, Susoctocog alfa (bhk))
Replagal® (agalsidase alfa ghu)
Revestive® (teduglutide)
Rixubis® (recombinant coagulation factor IX (rFIX), nonacog gamma (rch))
Somac® Injection (pantoprazole sodium)
Somac® (pantoprazole sodium sesquihydrate)
Somac® Heartburn Relief (pantoprazole sodium sesquihydrate)
Takhzyro® (Lanadelumab)
Vpriv® (velaglucerase alfa ghu)
Vyvanse® (lisdexamfetamine dimesilate)